Roberts Glore & Co. Inc. IL lessened its position in Albemarle Co. (NYSE:ALB – Free Report) by 6.6% in the 4th quarter, Holdings Channel.com reports. The fund owned 2,883 shares of the specialty chemicals company’s stock after selling 203 shares during the period. Roberts Glore & Co. Inc. IL’s holdings in Albemarle were worth $248,000 at the end of the most recent quarter.
Several other institutional investors have also recently made changes to their positions in ALB. Farther Finance Advisors LLC lifted its holdings in shares of Albemarle by 3.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 2,832 shares of the specialty chemicals company’s stock worth $268,000 after acquiring an additional 102 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in shares of Albemarle by 19.8% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 29,129 shares of the specialty chemicals company’s stock worth $2,759,000 after acquiring an additional 4,813 shares during the last quarter. Asset Management One Co. Ltd. lifted its holdings in shares of Albemarle by 0.8% in the 3rd quarter. Asset Management One Co. Ltd. now owns 43,996 shares of the specialty chemicals company’s stock worth $4,167,000 after acquiring an additional 344 shares during the last quarter. QRG Capital Management Inc. lifted its holdings in shares of Albemarle by 41.1% in the 3rd quarter. QRG Capital Management Inc. now owns 13,845 shares of the specialty chemicals company’s stock worth $1,311,000 after acquiring an additional 4,031 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in Albemarle by 3.2% during the 3rd quarter. Principal Financial Group Inc. now owns 135,194 shares of the specialty chemicals company’s stock valued at $12,804,000 after buying an additional 4,131 shares in the last quarter. Institutional investors own 92.87% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently weighed in on ALB. BMO Capital Markets decreased their price objective on shares of Albemarle from $150.00 to $140.00 in a report on Wednesday, February 12th. KeyCorp decreased their price objective on shares of Albemarle from $127.00 to $122.00 and set an “overweight” rating for the company in a report on Friday, February 14th. Citigroup decreased their price objective on shares of Albemarle from $115.00 to $85.00 and set a “neutral” rating for the company in a report on Wednesday, February 12th. Scotiabank decreased their price objective on shares of Albemarle from $85.00 to $75.00 and set a “sector perform” rating for the company in a report on Tuesday, February 18th. Finally, Piper Sandler decreased their price objective on shares of Albemarle from $90.00 to $85.00 and set an “underweight” rating for the company in a report on Thursday, February 20th. Two research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and six have assigned a buy rating to the stock. According to data from MarketBeat, Albemarle currently has an average rating of “Hold” and a consensus price target of $107.05.
Albemarle Stock Down 1.2 %
Shares of Albemarle stock opened at $75.57 on Friday. The firm’s 50 day moving average price is $83.92 and its 200-day moving average price is $91.91. The company has a quick ratio of 1.19, a current ratio of 1.95 and a debt-to-equity ratio of 0.39. Albemarle Co. has a 52-week low of $67.23 and a 52-week high of $137.50. The company has a market cap of $8.88 billion, a P/E ratio of -6.75 and a beta of 1.70.
Albemarle (NYSE:ALB – Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. On average, sell-side analysts predict that Albemarle Co. will post -0.04 EPS for the current fiscal year.
Albemarle Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 1st. Shareholders of record on Friday, March 14th will be given a dividend of $0.405 per share. This represents a $1.62 annualized dividend and a yield of 2.14%. The ex-dividend date of this dividend is Friday, March 14th. Albemarle’s dividend payout ratio is presently -14.46%.
Albemarle Company Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
See Also
- Five stocks we like better than Albemarle
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Institutional Investors Bet $1B on These 4 Stocks—Should You?
- The Significance of Brokerage Rankings in Stock Selection
- One Must-Buy Stock and One to Avoid as Tariffs Shake the Market
- Bank Stocks – Best Bank Stocks to Invest In
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
Want to see what other hedge funds are holding ALB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Albemarle Co. (NYSE:ALB – Free Report).
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.